Global Contrast Agents Market Insights, Forecast to 2025
Contrast agents are chemicals, which are used to enhance the image effect to observe by injecting (or taking) into human tissue or organs. The density of contrast agents is higher or lower than surrounding tissue and this contrast can display images via some device.
Contrast agents are widely used in diagnostic imaging procedures such as CT scans, MRIs, X-rays, ultrasounds, and related procedures.
In terms of volume, the production of contrast agents was about 242794 K Dose in 2015 and is anticipated to reach 329523 K Dose by 2021.
The contrast agents industry is a quite concentrated market with a few companies dominates the market. Bayer is the dominate producer of contrast agents, the production was 74476 K Dose in 2015, accounting for about 30.67% of the total amount, followed by GE Healthcare, with the production market share of 25.54 %. The top four companies occupied about 79.40 % production share of the market in 2015.
At present, in the foreign industrial developed countries the contrast agents industry is generally at a more advanced level, the world's large enterprises are mainly concentrated in the North America
Europe and Japan, accounted for most of the international market share. Meanwhile, these companies have more advanced equipment, strong R&D capabilities; the technical level is in a leading position.
The emerging markets (such as China, India) have relatively small scales. However, they have much higher market increasing growth than developed countries. They are the main growth areas in the global contrast agents market.
The sales volume shares of North America, Europe, Japan, China, India and Southeast Asia were 27.91%, 19.65%, 22.52%, 11.07%, 7.35% and 3.52%.
There are mainly two types of contrast agents: iodine preparations type and gadolinium preparations type. Currently, iodine preparations type is the main product and it occupied 81 % share in 2015.
X-CT accounted for the largest market with about 85.10 % market share of the global contrast agents consumption in 2015. Moreover, it is anticipated to grow at a CAGR of 4.92 % from 2016 to 2021. With over 13 % share in the contrast agents market, MRI was the second largest application market in 2015, and is anticipated to grow at a CAGR of 5.71% in terms of consumption volume, from 2016 to 2021.
Under the influence of raw material, market competitions and economic conditions, the price of contrast agents was fluctuant in recent years. Over the next few years, we predict that price will decline. As competition intensifies, prices gap between different brands will go narrowing.
The global Contrast Agents market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Contrast Agents market based on company, product type, end user and key regions.
This report studies the global market size of Contrast Agents in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Contrast Agents in these regions.
This research report categorizes the global Contrast Agents market by top players/brands, region, type and end user. This report also studies the global Contrast Agents market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
GE Healthcare
Bracco Imaging
Guerbet Group
Hengrui Medicine
YRPG
Lantheus
BeiLu Pharma
Market size by Product
Iodine Preparations
Gadolinium Preparations
Others
Market size by End User
X-CT
MRI
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Contrast Agents market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Contrast Agents market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Contrast Agents companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Contrast Agents submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Contrast Agents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Dose). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Contrast Agents market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Contrast agents are widely used in diagnostic imaging procedures such as CT scans, MRIs, X-rays, ultrasounds, and related procedures.
In terms of volume, the production of contrast agents was about 242794 K Dose in 2015 and is anticipated to reach 329523 K Dose by 2021.
The contrast agents industry is a quite concentrated market with a few companies dominates the market. Bayer is the dominate producer of contrast agents, the production was 74476 K Dose in 2015, accounting for about 30.67% of the total amount, followed by GE Healthcare, with the production market share of 25.54 %. The top four companies occupied about 79.40 % production share of the market in 2015.
At present, in the foreign industrial developed countries the contrast agents industry is generally at a more advanced level, the world's large enterprises are mainly concentrated in the North America
Europe and Japan, accounted for most of the international market share. Meanwhile, these companies have more advanced equipment, strong R&D capabilities; the technical level is in a leading position.
The emerging markets (such as China, India) have relatively small scales. However, they have much higher market increasing growth than developed countries. They are the main growth areas in the global contrast agents market.
The sales volume shares of North America, Europe, Japan, China, India and Southeast Asia were 27.91%, 19.65%, 22.52%, 11.07%, 7.35% and 3.52%.
There are mainly two types of contrast agents: iodine preparations type and gadolinium preparations type. Currently, iodine preparations type is the main product and it occupied 81 % share in 2015.
X-CT accounted for the largest market with about 85.10 % market share of the global contrast agents consumption in 2015. Moreover, it is anticipated to grow at a CAGR of 4.92 % from 2016 to 2021. With over 13 % share in the contrast agents market, MRI was the second largest application market in 2015, and is anticipated to grow at a CAGR of 5.71% in terms of consumption volume, from 2016 to 2021.
Under the influence of raw material, market competitions and economic conditions, the price of contrast agents was fluctuant in recent years. Over the next few years, we predict that price will decline. As competition intensifies, prices gap between different brands will go narrowing.
The global Contrast Agents market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Contrast Agents market based on company, product type, end user and key regions.
This report studies the global market size of Contrast Agents in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Contrast Agents in these regions.
This research report categorizes the global Contrast Agents market by top players/brands, region, type and end user. This report also studies the global Contrast Agents market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
GE Healthcare
Bracco Imaging
Guerbet Group
Hengrui Medicine
YRPG
Lantheus
BeiLu Pharma
Market size by Product
Iodine Preparations
Gadolinium Preparations
Others
Market size by End User
X-CT
MRI
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Contrast Agents market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Contrast Agents market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Contrast Agents companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Contrast Agents submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Contrast Agents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Dose). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Contrast Agents market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
